How to submit

***UPDATE / APRIL 2020***

April 3 2020 memo - Special guidelines to research teams in the context of the Covid-19 pandemic

In the context of the COVID-19 pandemic, with the endorsement of the chairs of our research ethics committees, the Directorate of Academic Affairs and the research review office (RRO) of the CIUSSS Centre-Ouest-de-l'Île-de- Montréal have put in place temporary exceptional measures for the evaluation of new research projects and the monitoring of ongoing projects during the declared public emergency. These exceptional measures will be reviewed on a regular basis and an update will be made available on the establishment's Web site as the situation evolves.

Please note that funding, if required to conduct the study, must be secured before submitting your project to the REB. ( Follow this link to access memo).

March 27 2020 - COVID-19 : For Researchers submitting a COVID-19 related research project to the Research Review Office  and the CIUSSS-West Central Montreal Research Ethics Board :

  • If you plan on submitting a COVID-19 related research project to the Research Ethics Committee please contact Kathleen Blagrave (kblagrave@jgh.mcgill.ca) as soon as the project is submitted in Nagano so that it can be quickly triaged.
  • Please see the flow chart  for more information regarding the process for the review of COVID-19 related studies.

The Research Review Office can provide assistance with submissions, if required.  Please contact cer@jgh.mcgill.ca for more information.


How you submit a research project through NAGANO depends on the type of project, and how many sites will participate in research.

 ccomtl.nagano.ca

Research privileges are required to conduct research activities with CIUSSS West-Central Montreal staff or clients (using one of its facilities or integrated sites and including the clientele of its territory who are benefiting from treatment and home care). The request to obtain research privileges is made before the submission of a research study to the Research Review Office. The office can help to determine whether the researcher must submit a request for research privileges and refers them to the person designated for Medical / Biomedical research stream or for First-Line or Psychosocial research stream.


MONO-CENTRIC PROJECTS:

  • A research project evaluated at the CIUSSS West-Central Research Ethics Board for which the research activities will be executed only at the CIUSSS West-Central installation(s) (e.g. Jewish General Hospital, Maimonides, CLSC de la Montagne, Constance-Lethbridge Rehabilitation Center, etc).
  • A Research project evaluated at the CRIR Research Ethics Board for which the research activities will be executed at the CIUSSS West-Central installation(s).

MULTI-CENTRIC PROJECTS:

  • A research project evaluated at the CIUSSS West-Central Research Ethics Board, for which the research activities will be executed at the CIUSSS West-Central installation(s) and at other institutions.
  • A research project evaluated at another REB (other than the CIUSSS West-Central Research Ethics Board) for which the activities will be executed at local sites , in this case, at the CIUSSS West-Central installation(s).

The 4 steps to begining your research activities: 

1. ETHICS REVIEW

Ethics review is an evaluation based on best practices in research ethics in terms of protecting the participant. The CIUSSS West-Central Montreal Research Ethics Board holds two sub-committes: 

  1. Medical-Biomedical (MBM) committee
    • medical research, clinical trials, biobanks, etc.
  2. Psychosocial (PSY)committee
    • psychosocial research, gerontology research, education, etc.

2. SCIENTIFIC REVIEW

Science review is an evaluation based on good scientific practices at the methodological level, in relation to research hypotheses, research groups, etc. At CIUSSS West-Central Montreal, we have a scientific evaluation committee available for research protocols that have not already been scientifically evaluated. In the case where a scientific evaluation already exists, it will be possible to download it directly in the NAGANO initial submission form.

3. FEASIBILITY REVIEW & CONTRACT

Feasibility review is an assessment of the material and human resources related to the research project. This evaluation is the responsibility of the department or program where your research will be performed. The contract is a legal document of agreement between the sponsor and the institution A contract is necessary for privately-funded clinical research, and not applicable to projects with public funding. At CIUSSS West-Central Montreal, the feasibility review is initiated directly by answering the questions in the initial NAGANO submission form.

4. INSTITUTIONAL AUTHORISATION

An authorization issued by the Office of the person in charge at CIUSSS West-Central Montreal to authorize research that includes the three previous evaluations. Without this final document, the research team is not authorized to start research activities in the institution. At CIUSSS West-Central Montreal, institutional authorization will be issued via NAGANO.


At the RRO, Submissions are processed one of three ways:

  • Full Board Review: Studies that involve risks to participants for the advancement of scientific knowledge are revised at full board meetings.
  • Delegated Review: Studies can be reviewed in a delegated fashion if the study does not involve more than minimal risk. The standard of minimal risk is commonly defined as follows: if potential subjects can reasonably be expected to regard the probability and magnitude of possible harms implied by participation in the research to be no greater than those encountered by the subject in those aspects of his or her everyday life that relate to the research then the research can be regarded as within the range of minimal risk.  Delegated approval is granted by the Chair and the protocol is then presented for corroborative approval at the next Research Ethics Committee Meeting.
  • Chart Review: A retrospective Chart Review must be authorized both by the Research Ethics Board and the Director of Professional Services according to article 19.2 de la Loi sur les services de santé et des services sociaux.

Amendments to a protocol

After a protocol is approved and activated, any modifications or amendments must be submitted promptly to the Research Ethics Board (REB) through Nagano for review and approval prior to this modification being implemented. Some may require a full committee review for approval, particularly if the amendment is major, or if the protocol itself has been significantly changed. An example of a major amendment would be substantial changes in inclusion and exclusion criteria.

When an amendment to the protocol involves changes to the consent form, the consent form must be changed to reflect the approved change, and participant consent is often required again.

Page last updated on 

We always seek feedback to make our site better.